Tocilizumab also known as atlizumab, is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration. It has a high affinity to IL-6R and blocks the IL-6 signaling by preventing the formation of the IL-6/IL-6R complex. Tocilizumab is used for the treaent of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. Anti-Tocilizumab Antibody (6C10), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Tocilizumab.
Clonality:
Monoclonal
Clone Designation:
[6C10]
Purity:
Protein A chromatography
Form:
Purified
Target:
Tocilizumab
Application Dilute:
Reconstitute Lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/ml Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by seco
* VAT and and shipping costs not included. Errors and price changes excepted
